HALOZYME REPORTS SECOND QUARTER 2023 FINANCIAL AND OPERATING RESULTS
Go back to HALOZYME REPORTS SECOND QUARTER 2023 FINANCIAL AND OPERATING RESULTS| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 69.45 -1.28 (1.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $70.73 | 52 Week High | $18.39 | |||
| Open | $71.01 | 52 Week Low | $6.96 | |||
| Day High | $71.81 | P/E | N/A | |||
| Day Low | $69.33 | EPS | $-0.58 | |||
| Volume | 169,964 | |||||
